Excited to see our work on the cover of @molsystbiol.org! Cover art by Laura Seclì shows barcoded #stemcell clones navigating inducible perturbations: iPS2-seq reads each trajectory, and catcheR sorts clones—highlighting SMAD2 as a key #cardiac regulator and capturing epigenetically biased outliers.
03.02.2026 15:43
👍 3
🔁 0
💬 0
📌 0
iPS2-seq is a clone-aware platform for #singlecell loss-of-function screening in #hiPSCs and derivatives including #organoids, here revealing SMAD2 role in cardiac progenitor specification from @berterolab.bsky.social @mendjanlab.bsky.social #functionalgenomics ➡️ link.springer.com/article/10.1...
03.02.2026 15:20
👍 1
🔁 1
💬 0
📌 0
💸 Stem cell culture that’s ~95% cheaper and weekend-free: a win-win for PIs and trainees!
Our revised manuscript is online at ORE: open-research-europe.ec.europa.eu/articles/4-1...
Benchmarked across cell lines & differentiation protocols, including scRNA-seq — with lessons for #cultivatedmeat too!
20.09.2025 14:41
👍 23
🔁 8
💬 0
📌 0
A tour de force that elevates the #CALIPERS technology to a whole new level! A must read for all iPSCs, cell cycle, and developmental biology aficionados.
08.07.2025 10:05
👍 4
🔁 2
💬 0
📌 1
#CALIPERSv2 🚀 preprint is locked—journal submission next. Final polish, more hiPSC reference lines, and fresh light-sheet data. Still, a great collaboration led by @moisesdisante with the team @LabPhysiology and the amazing @berterolab.bsky.social and @florianjug.bsky.social group members! 1/N
08.07.2025 09:36
👍 8
🔁 4
💬 1
📌 2
This is the way forward: here’s hope the “Fondo Italiano per la Scienza” will embrace this model instead of performing long, expensive, and less rigorous new evaluations (plus asking scientists to rewrite in ~half the space an already dense project)
17.04.2025 05:22
👍 8
🔁 0
💬 1
📌 0
Yup. What an effective way to speed up the sixth mass extinction
30.03.2025 07:45
👍 2
🔁 0
💬 0
📌 0
Blood chilling list. The nightmare continues
29.03.2025 11:55
👍 1
🔁 0
💬 0
📌 0
Honored to be recognized as a 2025 @isscr.org Public Service Award Honoree for my commitment to the Early Career Advisory Committee! Supporting early-career scientists has been a rewarding journey I am very proud of. Read more about the award and my fellow honorees: invt.io/1lxbo0wcokz
22.03.2025 20:52
👍 6
🔁 1
💬 0
📌 0
National Facilities - Human Technopole
🚀 The first 2025 Call for Access for our National Facilities is now open! Researchers can apply for cutting-edge services in the fields of omics, imaging and data analysis. Submit your proposal by 31 May!
Apply here 👉 humantechnopole.it/en/national-...
17.02.2025 11:28
👍 9
🔁 5
💬 0
📌 1
It’s a startup, so only time will tell if it will catch on and scale, but the technology seems solid
15.02.2025 15:12
👍 1
🔁 0
💬 0
📌 0
Point Zero – Break through the future
Indeed; we need innovations also in these sectors, such as the zero-emission brakes from #pointzero: www.point-zero.it
15.02.2025 13:38
👍 1
🔁 0
💬 1
📌 0
FEBS Press
The toolbox to manipulate gene function in human pluripotent stem cell models is large and growing: we review the state-of-the-art methods to perform robust loss-, gain-, and change-of-function studi...
Thanks to @erc.europa.eu for funding and publishing support, as well as @ec.europa.eu #NRRP & Giovanni Armenise-Harvard Foundation #CDA. If you made it this far, you may also be interested in our recent @febspress.bsky.social review on this topic: febs.onlinelibrary.wiley.com/doi/full/10.... 10/10
10.02.2025 23:05
👍 2
🔁 0
💬 0
📌 0
This is our second study on Open Research Europe, the @erc.europa.eu platform with transparent post-publication peer review, full open access, and no outrageous fees. I couldn’t be happier with this choice for both me and my student: a real breath of fresh air in today’s publishing landscape. 9/10
10.02.2025 23:05
👍 5
🔁 0
💬 1
📌 0
Here’s where we stand: I hope this helps others facing the same issue! Our manuscript formally passed peer review, but we're still tackling the reviewers’ remaining concerns (more on this below). Always open to suggestions: this is how science should work, IMHO. 8/10
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
Running low on options, we learned of Antonella Fidanza's @elife.bsky.social study using sodium butyrate to enhance a similar dox-inducible system. This strategy finally gave us >90% response in hiPSC-CMs—an effective fix, though relying on an epigenetic modulator isn't always ideal. 7/10
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
With AAVS1 silencing now widely reported, we turned to the CLYBL locus—touted as a better alternative in @plosone.org a few years back (journals.plos.org/plosone/arti...). Even when using insulators as in the original study, we saw mixed results: a glass half full, half empty, once again. 6/10
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
As we searched for answers, @johanneszuber.bsky.social kindly pointed us to an elegant @cp-cellrepmethods.bsky.social paper using a UCOE to stabilize TRE3VG (doi.org/10.1016/j.cr...). It improved inducibility in hPSC-derived cardiomyocytes, but was still far from perfect in this hard setting 5/10
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
For years, I suspected that the alternative dox-inducible promoter T11 might help. But between postdoc on other topics and a pandemic, testing had to wait—until Michelle, a master’s student in my lab, took on the challenge. Turns out I was dead wrong: it was worse than standard TRE3VG in hPSCs! 4/10
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
Turns out, this wasn’t just bad luck: it was a widespread issue, well-known yet rarely reported (as negative results often are). Why does it matter? Robust inducible gain-of-function experiments are crucial for both discovery and translational studies, and hPSCs are the most versatile cell type 310
10.02.2025 23:05
👍 1
🔁 0
💬 1
📌 0
This issue has frustrated me for a decade! During my PhD, we found that an otherwise excellent dox-inducible system failed to activate in many hPSC-derived cell types—including my favorite: cardiomyocytes. Fig. S7 from our @dev-journal.bsky.social paper 2/10
journals.biologists.com/dev/article/...
10.02.2025 23:05
👍 0
🔁 0
💬 1
📌 0
Struggling with #silencing of doxycycline-inducible transgenes in human pluripotent #stemcell derived lineages? You're not alone! In my very first #skeetorial I break down our latest paper on potential solutions to this common problem. Read on! 1/10
open-research-europe.ec.europa.eu/articles/4-2...
10.02.2025 23:05
👍 4
🔁 0
💬 1
📌 0
Amazing finding that could have broad implications also for cultivated meat production
10.02.2025 19:59
👍 0
🔁 0
💬 1
📌 0
Superb review from my friends and colleagues in @porpolab.bsky.social that helped me finally grasp the complexity of this often-overlooked disease in cancer patients. Bookmark it and give the authors a follow!
09.02.2025 18:05
👍 0
🔁 0
💬 0
📌 0
Brilliant work from @grazianomartello.bsky.social, tackling a major shift in the stem cell field to unlock large-scale experimentation with naïve human pluripotent stem cells. Great to see so many friends on the author list—science truly takes a village!
09.02.2025 17:39
👍 4
🔁 1
💬 0
📌 0
Seeing is believing! My friends and colleagues in Pavia have delivered a tour de force, packed with stunning images. @fspasqualini.bsky.social is reshaping how I see biology—his preprints might just change your perspective too!
09.02.2025 17:34
👍 2
🔁 0
💬 1
📌 0
Hello @bsky.app! Excited to join this island of science escapism in a world going madder each day. We’re the Armenise-Harvard Lab of Genome Architecting at the University of Torino, Italy, applying #stemcell, #CRISPR, #genomics, and #imaging to explore heart #development, #regeneration, and #cellag.
06.02.2025 12:18
👍 10
🔁 3
💬 0
📌 0